Tech Company Financing Transactions
AposTherapy Funding Round
aMoon Partners and private investors participated in a $11 million Series A funding round for AposTherapy. The round was announced on 2/19/2020.
Transaction Overview
Company Name
Announced On
2/19/2020
Transaction Type
Venture Equity
Amount
$11,000,000
Round
Series A
Investors
Proceeds Purpose
This new funding round will be used to support the rapid expansion into new territories with increased sales capabilities, account management expertise, and direct to consumer marketing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
300 Park Ave. 12th Floor
New York, NY 10022
USA
New York, NY 10022
USA
Phone
Website
Email Address
Overview
Apos Medical Assets Ltd. is a global medical device company, owned by leading healthcare fund aMoon and operating in four countries: the United States, the United Kingdom, Singapore and Israel. Founded in 2005, the company distributes the FDA cleared and CE marked AposTherapy treatment to both large hospitals and private clinicians' practices.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Clifford Bleustein
Chief Financial Officer
Omer Ostro
Chief Operating Officer
Avi Rozen
Vice President
Shelley Gnall
Vice President
Sachin Gohil
VP - Customer Service
Alon Yefet
VP - Marketing
Benjamin Feldman
VP - Operations
Stuart Bretz
VP - R & D
Oren Livne
VP - R & D
Ganit Segal
VP - Sales
Seth Klein
Browse more venture capital transactions:
Prev: 2/19/2020: MotoRefi venture capital transaction
Next: 2/19/2020: Immediate venture capital transaction
Share this article
Where The Data Comes From
We document every notable VC transaction. All VC database entries on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs